Evaluation of fibrotic liver disease with whole-liver t1r MR imaging: A feasibility study at 1.5 T

Radiology

Volumn 271, Issue 2, 2014, Pages 408-415

  Allkemper, Thomas ^a   Sagmeister, Florian ^a   Cicinnati, Vito ^a   Beckebaum, Susanne ^a   Kooijman, Hendrik ^b   Kanthak, Christian ^c   Stehling, Christoph ^a   Heindel, Walter ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b PHILIPS HEALTHCARE   (United States)

^c FRAUNHOFER MEVIS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHILD PUGH SCORE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEASIBILITY STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; LIVER BIOPSY; LIVER FIBROSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84899576593     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13130342     Document Type: Article

References (34)

1. Faria SC, Ganesan K, Mwangi I, et al. MR imaging of liver fibrosis: current state of the art. Radio Graphics 2009;29(6):1615-1635.
2. Sirlin CB. Science to practice: Can T1rho imaging be used to diagnose and assess the severity of hepatic fibrosis? Radiology 2011;259(3):619-620.
3. Zhao F, Deng M, Yuan J, Teng GJ, Ahuja AT, Wang YX. Experimental evaluation of accelerated T1rho relaxation quantification in human liver using limited spin-lock times. Korean J Radiol 2012;13(6):736-742.
4. Beckebaum S, Iacob S, Klein CG, et al. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients. Transplantation 2010;89(8):983-993.
5. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97(10):2614-2618.
6. Schmeltzer PA, Talwalkar JA. Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol Clin North Am 2011;40(3):507-521.
7. Deng M, Zhao F, Yuan J, Ahuja AT, Wang YX. Liver T1r MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence. Br J Radiol 2012;85(1017):e590-e595.
8. Wang YX, Yuan J, Chu ES, et al. T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model. Radiology 2011;259(3):712-719.
9. Duvvuri U, Goldberg AD, Kranz JK, et al. Water magnetic relaxation dispersion in biological systems: the contribution of proton exchange and implications for the noninvasive detection of cartilage degradation. Proc Natl Acad Sci U S A 2001;98(22):12479-12484.
10. Haris M, McArdle E, Fenty M, et al. Early marker for Alzheimer's disease: hippocampus T1rho (T(1rho)) estimation. J Magn Reson Imaging 2009;29(5):1008-1012.
11. Knispel RR, Thompson RT, Pintar MM. Dispersion of proton spin-lattice relaxation in tissues. J Magn Reson 1974;14(1):44-51.
12. Nestrasil I, Michaeli S, Liimatainen T, et al. T1rho and T2rho MRI in the evaluation of Parkinson's disease. J Neurol 2010;257(6):964-968.
13. Nguyen AM, Johannessen W, Yoder JH, et al. Noninvasive quantification of human nucleus pulposus pressure with use of T1rhoweighted magnetic resonance imaging. J Bone Joint Surg Am 2008;90(4):796-802.
14. Szyperski T, Luginbühl P, Otting G, Güntert P, Wüthrich K. Protein dynamics studied by rotating frame 15N spin relaxation times. J Biomol NMR 1993;3(2):151-164.
15. Hussain SM, Reinhold C, Mitchell DG. Cirrhosis and lesion characterization at MR imaging. Radio Graphics 2009;29(6):1637-1652.
16. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60(8):646-649.
17. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19(12):1409-1417.
18. Charagundla SR, Borthakur A, Leigh JS, Reddy R. Artifacts in T(1rho)-weighted imaging: correction with a self-compensating spin-locking pulse. J Magn Reson 2003;162(1):113-121.
19. Du J, Carl M, Diaz E, et al. Ultrashort TE T1rho (UTE T1rho) imaging of the Achilles tendon and meniscus. Magn Reson Med 2010;64(3):834-842.
20. Li X, Han ET, Busse RF, Majumdar S. In vivo T(1rho) mapping in cartilage using 3D magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo snapshots (3D MAPSS). Magn Reson Med 2008;59(2):298-307.
21. Marquardt DW. An algorithm for leastsquares estimation of nonlinear parameters. J Soc Ind Appl Math 1963;11(2):431-441.
22. Browne MW, Cudeck R, Bollen KA. Alternative ways of assessing model fit. In: Bollen KA, Long JS, eds. Testing structural equation models. Beverly Hills, Calif: Sage, 1993; 136-165.
23. Steiger JH. Point estimation, hypothesis testing, and interval estimation using the RMSEA: Some comments and a reply to Hayduk and Glaser. Struct Equ Modeling 2000;7(2):149-162.
24. Faul F, Erdfelder E, Lang AG, Buchner AG. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39(2):175-191.
25. Fleiss JL. Reliability of measurement: the design and analysis of clinical experiments. New York, NY: Wiley, 1986.
26. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006;239(2):425-437.
27. Balassy C, Feier D, Peck-Radosavljevic M, et al. Susceptibility-weighted MR imaging in the grading of liver fibrosis: a feasibility study. Radiology 2013 Aug 7. [Epub ahead of print].
28. Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 2009;50(1):17-35.
29. Ito K, Mitchell DG. Imaging diagnosis of cirrhosis and chronic hepatitis. Intervirology 2004;47(3-5):134-143.
30. Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol 2011;46(4):277-283.
31. Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging. Eur J Radiol 2012;81(7):1460-1464.
32. Salameh N, Larrat B, Abarca-Quinones J, et al. Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology 2009;253(1):90-97.
33. Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 2008;47(1):332-342.
34. Collins CM, Li S, Smith MB. SAR and B1 field distributions in a heterogeneous human head model within a birdcage coil. Specific energy absorption rate. Magn Reson Med 1998;40(6):847-856.